trending Market Intelligence /marketintelligence/en/news-insights/trending/vb_uxzjtxkrihvtz1zgg2g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Shire increases maximum tender offer for Baxalta debt to $2.33B

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Shire increases maximum tender offer for Baxalta debt to $2.33B

Shire PLC said it increased the maximum tender amount of certain outstanding senior notes of its unit Baxalta to $2.33 billion from $2.25 billion.

Illinois-based Baxalta, Shire's wholly owned subsidiary, develops products for hemophilia, immunology and oncology.

Other terms and conditions for the tender offer remain unchanged, the Dublin-based biotechnology company said.

Citigroup Global Markets Ltd. and Morgan Stanley & Co. LLC are acting as dealer managers, with Global Bondholder Services Corp. acting as depository and information agent.